276 related articles for article (PubMed ID: 31369682)
1. Structural insights into the design of indole derivatives as tubulin polymerization inhibitors.
Li Y; Yang J; Niu L; Hu D; Li H; Chen L; Yu Y; Chen Q
FEBS Lett; 2020 Jan; 594(1):199-204. PubMed ID: 31369682
[TBL] [Abstract][Full Text] [Related]
2. New indole-based chalconoids as tubulin-targeting antiproliferative agents.
Mirzaei H; Shokrzadeh M; Modanloo M; Ziar A; Riazi GH; Emami S
Bioorg Chem; 2017 Dec; 75():86-98. PubMed ID: 28922629
[TBL] [Abstract][Full Text] [Related]
3. Structure of a benzylidene derivative of 9(10H)-anthracenone in complex with tubulin provides a rationale for drug design.
Cheng J; Wu Y; Wang Y; Wang C; Wang Y; Wu C; Zeng S; Yu Y; Chen Q
Biochem Biophys Res Commun; 2018 Jan; 495(1):185-188. PubMed ID: 29102632
[TBL] [Abstract][Full Text] [Related]
4. Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery.
Wang Y; Zhang H; Gigant B; Yu Y; Wu Y; Chen X; Lai Q; Yang Z; Chen Q; Yang J
FEBS J; 2016 Jan; 283(1):102-11. PubMed ID: 26462166
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site.
Li L; Jiang S; Li X; Liu Y; Su J; Chen J
Eur J Med Chem; 2018 May; 151():482-494. PubMed ID: 29649743
[TBL] [Abstract][Full Text] [Related]
6. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization.
Coluccia A; Sabbadin D; Brancale A
Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885
[TBL] [Abstract][Full Text] [Related]
7. Structure of 4'-demethylepipodophyllotoxin in complex with tubulin provides a rationale for drug design.
Niu L; Wang Y; Wang C; Wang Y; Jiang X; Ma L; Wu C; Yu Y; Chen Q
Biochem Biophys Res Commun; 2017 Nov; 493(1):718-722. PubMed ID: 28864414
[TBL] [Abstract][Full Text] [Related]
8. A Rationale for Drug Design Provided by Co-Crystal Structure of IC261 in Complex with Tubulin.
Xian J; Bu F; Wang Y; Long F; Zhang Z; Wu C; Tao Y; Wang T; Wang G
Molecules; 2021 Feb; 26(4):. PubMed ID: 33579052
[TBL] [Abstract][Full Text] [Related]
9. New ligands of the tubulin colchicine site based on X-ray structures.
Álvarez R; Medarde M; Peláez R
Curr Top Med Chem; 2014; 14(20):2231-52. PubMed ID: 25434358
[TBL] [Abstract][Full Text] [Related]
10. Fragment based group QSAR and molecular dynamics mechanistic studies on arylthioindole derivatives targeting the α-β interfacial site of human tubulin.
Tyagi C; Gupta A; Goyal S; Dhanjal J; Grover A
BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S3. PubMed ID: 25521775
[TBL] [Abstract][Full Text] [Related]
11. Indole derivatives (2010-2020) as versatile tubulin inhibitors: synthesis and structure-activity relationships.
Naaz F; Neha K; Haider MR; Shafi S
Future Med Chem; 2021 Oct; 13(20):1795-1828. PubMed ID: 34468201
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of indole-2-carbohydrazides and thiazolidinyl-indole-2-carboxamides as potent tubulin polymerization inhibitors.
Kazan F; Yagci ZB; Bai R; Ozkirimli E; Hamel E; Ozkirimli S
Comput Biol Chem; 2019 Jun; 80():512-523. PubMed ID: 31185422
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in research of colchicine binding site inhibitors and their interaction modes with tubulin.
Sun K; Sun Z; Zhao F; Shan G; Meng Q
Future Med Chem; 2021 May; 13(9):839-858. PubMed ID: 33821673
[TBL] [Abstract][Full Text] [Related]
14. Structure-Guided Design, Synthesis, and Biological Evaluation of (2-(1
Wang Q; Arnst KE; Wang Y; Kumar G; Ma D; White SW; Miller DD; Li W; Li W
J Med Chem; 2019 Jul; 62(14):6734-6750. PubMed ID: 31251599
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, biological evaluation, and molecular docking of new benzofuran and indole derivatives as tubulin polymerization inhibitors.
El-Sayed NF; El-Hussieny M; Ewies EF; El Shehry MF; Awad HM; Fouad MA
Drug Dev Res; 2022 Apr; 83(2):485-500. PubMed ID: 34523738
[TBL] [Abstract][Full Text] [Related]
16. Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents.
Patil SA; Patil R; Miller DD
Future Med Chem; 2012 Oct; 4(16):2085-115. PubMed ID: 23157240
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 2,4,5-substituted pyrimidines as a new class of tubulin polymerization inhibitors.
Xie F; Zhao H; Li D; Chen H; Quan H; Shi X; Lou L; Hu Y
J Med Chem; 2011 May; 54(9):3200-5. PubMed ID: 21480626
[TBL] [Abstract][Full Text] [Related]
18. Indole based Tubulin Polymerization Inhibitors: An Update on Recent Developments.
Sunil D; Kamath PR
Mini Rev Med Chem; 2016; 16(18):1470-1499. PubMed ID: 27468786
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of 2-alkoxycarbonyl-3-anilinoindoles as a new class of potent inhibitors of tubulin polymerization.
Romagnoli R; Prencipe F; Oliva P; Kimatrai Salvador M; Brancale A; Ferla S; Hamel E; Viola G; Bortolozzi R; Persoons L; Balzarini J; Liekens S; Schols D
Bioorg Chem; 2020 Apr; 97():103665. PubMed ID: 32086053
[TBL] [Abstract][Full Text] [Related]
20. Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents, an update (2013-2015).
Patil R; Patil SA; Beaman KD; Patil SA
Future Med Chem; 2016 Jul; 8(11):1291-316. PubMed ID: 27476704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]